Go to deals
TMT

B Communications Ltd. has issued bonds

B Communications Ltd. has completed a fundraising to develop the company.

B Communications is an Israeli corporation focused on the telecommunications industry. Its shares are traded on the Tel-Aviv Stock Exchange under the symbol BCOM. B Communications’ sole asset is its controlling interest (approximately 26.72%) in Bezeq The Israel Telecommunication Corp, Ltd. (TASE:BZEQ), Israel’s incumbent telecommunications group. Bezeq Group is the country’s largest telco group with a clear leadership position. It is active in mobile voice, internet services, international long-distance (ILD) services and multichannel pay TV.

Oaklins’ team in Israel advised the company and acted as the leader of the distributors’ consortium.

Talk to the deal team

Boaz Levi

Partner
Tel Aviv, Israel
Oaklins Rosario

Related deals

BodhiCedric has acquired Network Media from Jellysmack
TMT

BodhiCedric has acquired Network Media from Jellysmack

The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.

Learn more
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
TMT

CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions

Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.

Learn more
Bayer AG has entered into a takeover agreement with Cara Care
Healthcare | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Learn more